These findings are supported by the decreased expression of TNFα protein following AO extract administration in the liver, because hepatic adiponectin induction may reduce NASH-related necro-inflammation and fibrosis via TNF-α antagonism and suppress each other’s secretion [41]. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatohepatitis.